JP2001513566A5 - - Google Patents

Download PDF

Info

Publication number
JP2001513566A5
JP2001513566A5 JP2000507383A JP2000507383A JP2001513566A5 JP 2001513566 A5 JP2001513566 A5 JP 2001513566A5 JP 2000507383 A JP2000507383 A JP 2000507383A JP 2000507383 A JP2000507383 A JP 2000507383A JP 2001513566 A5 JP2001513566 A5 JP 2001513566A5
Authority
JP
Japan
Prior art keywords
estrogen
combination
progestin
days
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2000507383A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001513566A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/017288 external-priority patent/WO1999009993A1/en
Publication of JP2001513566A publication Critical patent/JP2001513566A/ja
Publication of JP2001513566A5 publication Critical patent/JP2001513566A5/ja
Ceased legal-status Critical Current

Links

JP2000507383A 1997-08-27 1998-08-20 経口避妊における、エストロゲンと子宮内膜節約性プロゲスチンおよび子宮内膜萎縮性プロゲスチンとの組み合わせ物 Ceased JP2001513566A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5710997P 1997-08-27 1997-08-27
US60/057,109 1997-08-27
PCT/US1998/017288 WO1999009993A1 (en) 1997-08-27 1998-08-20 Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception

Publications (2)

Publication Number Publication Date
JP2001513566A JP2001513566A (ja) 2001-09-04
JP2001513566A5 true JP2001513566A5 (enExample) 2006-01-05

Family

ID=22008560

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000507383A Ceased JP2001513566A (ja) 1997-08-27 1998-08-20 経口避妊における、エストロゲンと子宮内膜節約性プロゲスチンおよび子宮内膜萎縮性プロゲスチンとの組み合わせ物

Country Status (9)

Country Link
EP (1) EP1007052B1 (enExample)
JP (1) JP2001513566A (enExample)
AT (1) ATE279198T1 (enExample)
AU (1) AU9028098A (enExample)
DE (1) DE69827017T2 (enExample)
DK (1) DK1007052T3 (enExample)
ES (1) ES2230711T3 (enExample)
PT (1) PT1007052E (enExample)
WO (1) WO1999009993A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
CA2524474A1 (en) * 2003-05-02 2004-11-18 Duramed Pharmaceuticals, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
JP2007534622A (ja) * 2003-07-16 2007-11-29 デュラメド ファーマシューティカルズ インコーポレーティッド 連続的エストロゲン投与での避妊薬療法を利用するホルモン処置の方法
JP2007507534A (ja) * 2003-10-01 2007-03-29 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 持続的三相避妊方法
EP1535618A1 (en) 2003-11-26 2005-06-01 Schering Aktiengesellschaft Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4616006A (en) * 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
FI101601B1 (fi) * 1987-09-24 1998-07-31 Jencap Research Ltd Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmisteen valmistusmenetelmässä
DE4104385C1 (enExample) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich

Similar Documents

Publication Publication Date Title
YU14502A (sh) Farmaceutska kombinacija etinilestradiola i drospirenona za primenu kao kontraceptivnog sredstva
AR029159A1 (es) Preparacion farmaceutica, envase que la contiene y uso en la preparacion de un medicamento util en la terapia de reemplazo hormonal
WO2001064182A3 (en) Improvements in or relating to the delivery of oral drugs
RU99101114A (ru) Схемы приема прогестогена-антипрогестогена
ES2175650T3 (es) Anticonceptivos orales de dosis ultra baja con menos hemorragia menstrual y eficacia mantenida.
CA2240329A1 (en) Improved delivery of multiple doses of medications
AR031563A1 (es) Una composicion farmaceutica para emplear en el tratamiento de trastornos menopausicos o posmenopausicos de estrogenos y acetato de medroxiprogesterona, una unidad de dosificacion farmaceutica y uso de una combinacion de estrogenos conjugados y acetato de medroxiprogesterona para la manufactura de u
RU2001129160A (ru) Прерывистая гормонозаместительная терапия низкими дозами эстрогена
JP2004508398A5 (enExample)
JP2005505557A5 (enExample)
MY128482A (en) New hormonal composition and its use
KR970706004A (ko) 호르몬 약물 및 에스트로겐 결핍을 치유하기 위한 그의 용도(novel hormonal medicaments and use thereof for correcting oestrogen deficiencies)
JP2001513566A5 (enExample)
PL348202A1 (en) Pharmaceutically active composition and dispensing device
JP2003509467A5 (enExample)
RU2002111000A (ru) Способ терапевтического лечения внематочной пролиферации эндометриальной ткани, хронической боли в области таза и непроходимости фаллопиевых труб, фармацевтическая композиция и анатагонист LHRH-лекарственное средство для указанного лечения (варианты)
UA81387C2 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
ES2590914T3 (es) Preparación hormonal que contiene una combinación de etinilestradiol y acetato de clormadinona
IL126176A0 (en) A pharmaceutical agent containing oestrogen and progesterone for sequential hormone therapy and a packaging unit containing the same
JP2002520269A5 (enExample)
US6630149B1 (en) Blister containing a transdermal therapeutic system and a single dose form of administration
SI9300687A (en) Transdermal hormone replacement therapy
CO5200771A1 (es) Una composicion farmaceutica para ser usada como agente anticonceptivo
SK25299A3 (en) Transdermal therapeutical approach involving a combination of active substances containing oestriol
EP1178807A2 (en) Use of antiprogestagens in combined therapy